Back to Search
ROBERT SEGAL, MD
MD
Specialist
NPI: 1477621209Individual
Specialties, Licenses & Credentials
Research & Publications (20)
A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer.
PMID 19593565·Cancer Chemother Pharmacol·2010
3-trial
Anterograde transport of TrkB in axons is mediated by direct interaction with Slp1 and Rab27.
PMID 19460344·Dev Cell·2009
7-preclinical
Proteoglycan interactions with Sonic Hedgehog specify mitogenic responses.
PMID 19287388·Nat Neurosci·2009
7-preclinical
Dosimetry of nasal uptake of water-soluble and reactive gases: a first study of interhuman variability.
PMID 19459775·Inhal Toxicol·2009
4-observational
Tube feeding with a diabetes-specific feed for 12 weeks improves glycaemic control in type 2 diabetes patients.
PMID 19501937·Clin Nutr·2009
2-rct
Predictors of follow-up exercise behavior 6 months after a randomized trial of exercise training during breast cancer chemotherapy.
PMID 18389368·Breast Cancer Res Treat·2009
2-rct
A retrograde neuronal survival response: target-derived neurotrophins regulate MEF2D and bcl-w.
PMID 19458239·J Neurosci·2009
7-preclinical
A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia.
PMID 19117865·Pediatrics·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 8000 CENTERVIEW PKWY, SUITE 300
CORDOVA, TN 38018 - Phone
- (901) 747-1111
Quick Facts
- NPI
- 1477621209
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile